v3.26.1
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   149,429,410      
Beginning balance at Dec. 31, 2024 $ (29,615) $ 15 $ 642,256 $ (25) $ (671,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (9,220)       (9,220)
Exercise stock options (in shares)   1,366,498      
Exercise of stock options 4,960   4,960    
Vesting of restricted stock units, net of shares withheld for tax (in shares)   3,721,805      
Vesting of restricted stock units, net of shares withheld for tax (7,998) $ 1 (7,999)    
Issuance of common stock upon conversion of convertible notes (in shares)   1,045,752      
Issuance of common shares in settlement of 2025 Convertible Debt 3,188   3,188    
Issuance of common shares in settlement of warrants (in shares)   450,585      
Stock-based compensation 3,557   3,557    
Ending balance (in shares) at Mar. 31, 2025   156,014,050      
Ending balance at Mar. 31, 2025 (35,128) $ 16 645,962 (25) (681,081)
Beginning balance (in shares) at Dec. 31, 2024   149,429,410      
Beginning balance at Dec. 31, 2024 (29,615) $ 15 642,256 (25) (671,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (11,148)        
Issuance of common shares in settlement of 2025 Convertible Debt 15,146        
Ending balance (in shares) at Jun. 30, 2025   161,224,762      
Ending balance at Jun. 30, 2025 (19,304) $ 16 663,713 (24) (683,009)
Beginning balance (in shares) at Mar. 31, 2025   156,014,050      
Beginning balance at Mar. 31, 2025 (35,128) $ 16 645,962 (25) (681,081)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (1,928)       (1,928)
Exercise stock options (in shares)   315,724      
Exercise of stock options 1,152   1,152    
Vesting of restricted stock units, net of shares withheld for tax (in shares)   680,154      
Vesting of restricted stock units, net of shares withheld for tax (859)   (859)    
Issuance of common stock upon conversion of convertible notes (in shares)   3,932,399      
Issuance of common shares in settlement of 2025 Convertible Debt 11,958   11,958    
Issuance of common stock through employee stock purchase plan (in shares)   282,435      
Issuance of common stock through employee stock purchase plan, value 830   830    
Stock-based compensation 4,670   4,670    
Other comprehensive (loss) gain 1     1  
Ending balance (in shares) at Jun. 30, 2025   161,224,762      
Ending balance at Jun. 30, 2025 (19,304) $ 16 663,713 (24) (683,009)
Beginning balance (in shares) at Dec. 31, 2025   166,215,410      
Beginning balance at Dec. 31, 2025 13,689 $ 17 685,004 (25) (671,307)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 2,234       2,234
Exercise stock options (in shares)   259,935      
Exercise of stock options 847   847    
Vesting of restricted stock units, net of shares withheld for tax (in shares)   3,808,125      
Vesting of restricted stock units, net of shares withheld for tax (17,017) $ 1 (17,018)    
Issuance of common shares in settlement of warrants (in shares)   2,275,313      
Issuance of common shares in settlement of warrants 7,333   7,333    
Stock-based compensation 5,924   5,924    
Other comprehensive (loss) gain 1     1  
Ending balance (in shares) at Mar. 31, 2026   172,558,783      
Ending balance at Mar. 31, 2026 13,011 $ 18 682,090 (24) (669,073)
Beginning balance (in shares) at Dec. 31, 2025   166,215,410      
Beginning balance at Dec. 31, 2025 13,689 $ 17 685,004 (25) (671,307)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income $ (28,867)        
Exercise stock options (in shares) 508,059        
Issuance of common shares in settlement of 2025 Convertible Debt $ 0        
Ending balance (in shares) at Jun. 30, 2026   173,591,637      
Ending balance at Jun. 30, 2026 (9,734) $ 18 690,432 (10) (700,174)
Beginning balance (in shares) at Mar. 31, 2026   172,558,783      
Beginning balance at Mar. 31, 2026 13,011 $ 18 682,090 (24) (669,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (31,101)       (31,101)
Exercise stock options (in shares)   248,124      
Exercise of stock options 580   580    
Vesting of restricted stock units, net of shares withheld for tax (in shares)   363,980      
Vesting of restricted stock units, net of shares withheld for tax (191)   (191)    
Issuance of common stock through employee stock purchase plan (in shares)   157,592      
Issuance of common stock through employee stock purchase plan, value 985   985    
Issuance of common shares in settlement of warrants (in shares)   263,158      
Issuance of common shares in settlement of warrants 600   600    
Stock-based compensation 6,368   6,368    
Other comprehensive (loss) gain 14     14  
Ending balance (in shares) at Jun. 30, 2026   173,591,637      
Ending balance at Jun. 30, 2026 $ (9,734) $ 18 $ 690,432 $ (10) $ (700,174)